Bausch Health
BHC
#3606
Rank
NZ$4.85 B
Marketcap
$13.22
Share price
2.00%
Change (1 day)
2.49%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -$4.29

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -$4.29. In 2022 the company made an earnings per share (EPS) of -$1.00 an increase over its 2021 EPS that were of -$4.30.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.29327.42%
2022-$1.00-76.64%
2021-$4.3068.45%
2020-$2.55-68.91%
2019-$8.20-57.11%
2018-$19.13-272.22%
2017$11.11-199.29%
2016-$11.19798.7%
2015-$1.24-128.31%
2014$4.40-204.62%
2013-$4.20602.7%
2012-$0.60-171.15%
2011$0.84-143.96%
2010-$1.91-206.57%
2009$1.79-11.2%
2008$2.022.46%
2007$1.97-7.58%
2006$2.13-14.29%
2005$2.4954%
2004$1.62-500%
2003-$0.40-141.67%
2002$0.97-4.76%
2001$1.02-175%
2000-$1.36-268%
1999$0.8114.94%
1998$0.7020.83%
1997$0.5853.83%
1996$0.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.62-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.44-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA